Investigational therapy focuses on slowing progression in mild to moderate Alzheimer's
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug ...
Aug 21, 2014
0
0